Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+6.26%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$251M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$35M |
| 2 |
Merck
MRK
|
+$29.3M |
| 3 |
Microsoft
MSFT
|
+$23.4M |
| 4 |
Occidental Petroleum
OXY
|
+$18.7M |
| 5 |
Yum China
YUMC
|
+$17.1M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$36.6M |
| 2 |
Intel
INTC
|
+$34.3M |
| 3 |
Deere & Co
DE
|
+$18.1M |
| 4 |
NVR
NVR
|
+$17.6M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
Sector Composition
| 1 | Technology | 19.66% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.21% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
626
DELISTED
Chimerix, Inc.
CMRX
| $943K | 0.02% |
203,695
+49,287
| +32% | +$228K |
|
627
W.R. Berkley
WRB
$27.4B
| $925K | 0.02% |
43,554
-79,347
| -65% | -$1.69M |
|
628
Preferred Bank
PFBC
$1.17B
| $923K | 0.02% |
15,710
-1,020
| -6% | -$59.9K |
|
629
Surmodics
SRDX
$459M
| $923K | 0.02% |
32,974
+3,070
| +10% | +$85.9K |
|
|
ASNA
630
DELISTED
Ascena Retail Group, Inc.
ASNA
| $922K | 0.02% |
+19,611
| New | +$922K |
|
631
WesBanco
WSBC
$3.07B
| $913K | 0.02% |
+22,454
| New | +$913K |
|
|
FARO
632
DELISTED
Faro Technologies
FARO
| $909K | 0.02% |
19,340
+6,100
| +46% | +$287K |
|
|
LMNX
633
DELISTED
Luminex Corp
LMNX
| $908K | 0.02% |
46,068
-57,950
| -56% | -$1.14M |
|
634
Seres Therapeutics
MCRB
$154M
| $905K | 0.02% |
+4,461
| New | +$905K |
|
635
STAAR Surgical
STAA
$1.37B
| $901K | 0.02% |
58,160
+47,690
| +455% | +$739K |
|
636
Warrior Met Coal
HCC
$3.08B
| $898K | 0.02% |
35,700
+21,620
| +154% | +$544K |
|
637
Corcept Therapeutics
CORT
$7.55B
| $891K | 0.02% |
49,310
+29,500
| +149% | +$533K |
|
|
TTPH
638
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $890K | 0.02% |
7,060
+1,670
| +31% | +$211K |
|
639
Blackbaud
BLKB
$3.33B
| $888K | 0.02% |
9,400
| – | – |
|
640
Agios Pharmaceuticals
AGIO
$2.07B
| $886K | 0.02% |
+15,500
| New | +$886K |
|
641
Digi International
DGII
$1.27B
| $880K | 0.02% |
92,097
+32,206
| +54% | +$308K |
|
642
Kroger
KR
$44.3B
| $873K | 0.02% |
31,800
-53,420
| -63% | -$1.47M |
|
643
Triumph Financial, Inc.
TFIN
$1.42B
| $872K | 0.02% |
27,696
+2,670
| +11% | +$84.1K |
|
|
EGIO
644
DELISTED
Edgio, Inc. Common Stock
EGIO
| $872K | 0.02% |
4,942
+3,205
| +185% | +$566K |
|
|
IPHS
645
DELISTED
Innophos Holdings, Inc.
IPHS
| $863K | 0.02% |
+18,462
| New | +$863K |
|
646
Heritage Financial
HFWA
$842M
| $862K | 0.02% |
27,982
+2,532
| +10% | +$78K |
|
647
CRA International
CRAI
$1.27B
| $859K | 0.02% |
19,105
+7,685
| +67% | +$346K |
|
648
Spire
SR
$4.5B
| $857K | 0.02% |
11,400
-520
| -4% | -$39.1K |
|
649
Allient
ALNT
$774M
| $855K | 0.02% |
38,751
+4,050
| +12% | +$89.4K |
|
650
Park-Ohio Holdings
PKOH
$310M
| $855K | 0.02% |
18,610
+4,400
| +31% | +$202K |
|